Alex Leech is the founder of Alchemab Therapeutics. Alchemab Therapeutics has raised $82M in total funding. Latest round: Series A. Based in Cambridge, UK.
Alex Leech founded Alchemab Therapeutics and served as its CEO, leading the company through its seed round in 2019 and a subsequent $82 million Series A financing in 2021. He built the biotech company from inception in 16 months. He now serves as Chair of the Board of Directors at 2N Pharma.
Full founder directory · Investor directory · Company funding database · Fundraising library